|
|
||||||||
Eur J Cardiothorac Surg 2004;25:1006-1010
© 2004 Elsevier Science NL
a Department of Pathophysiology and Laboratory of Biophysics of Circulation, St. Petersburg I.P. Pavlov Federal Medical University, St. Petersburg, Russian Federation
b Division of Cardiac Surgery, St. Petersburg Research Institute of Cardiology, St. Petersburg, Russian Federation
c Centre for Physiologic Gene Function, Karolinska Institute, Stockholm, Sweden
d Department of Surgery, Ulleval University Hospital, 0407 Oslo, Norway
Received 13 December 2003; received in revised form 3 February 2004; accepted 4 February 2004.
* Corresponding author. Tel.: +47-2211-9757; fax: +47-22-11-7470
e-mail: i.j.vaage{at}ioks.uio.no
| Abstract |
|---|
|
|
|---|
Key Words: Heart Ischemia Reperfusion Ventricular fibrillation Postconditioning
| 1. Introduction |
|---|
|
|
|---|
Recently, it has been shown that the heart can be effectively protected from reperfusion injury not only with preconditioning, but also with brief episodes of ischemia during the early reperfusion period following a pronounced ischemic insult: ischemic postconditioning [8]. In a dog model postconditioning limits infarct size, reduces tissue edema and polymorphonuclear neutrophil accumulation in the area at risk myocardium, and improves endothelial function [8]. It has been suggested that postconditioning is as effective as preconditioning in limiting infarct size and preserving postischemic endothelial function [8].
Another aspect of ischemia-reperfusion injury is reperfusion arrhythmias [9]. We hypothesized that postconditioning might convert serious reperfusion arrhythmias defined as persistent ventricular fibrillation (VF) into regular rhythm. In the present study this hypothesis was investigated in the isolated, perfused rat heart subjected to regional ischemia.
| 2. Materials and methods |
|---|
|
|
|---|
2.1. Isolated heart perfusion
Male Wistar rats weighing 250300 g used throughout the experiments received 60 mg/kg of pentobarbital sodium and 1000 units of heparin intraperitoneally. The thoracic cavity was opened by a wide transdiaphragmal bilateral incision, the hearts were quickly excised, arrested in ice-cold heparinized saline, and immediately mounted on the Langendorff apparatus by the aortic root. A modified KrebsHenseleit solution consisting of (in mM) 11 glucose, 118 NaCl, 4.7 KCl, 3.0 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 0.5 EDTA, and 25 NaHCO3 was equilibrated with 95% O2 and 5% CO2 and the pH maintained at about 7.4. The whole system was heated to 37 °C by means of water jacketing. Perfusion pressure was constant at 70 mmHg. The heart was suspended in a thermostatic chamber (37 °C).
To induce regional ischemia, the proximal length of left coronary artery was localized between left atrial appendage and the right ventricular outflow tract followed by the passage of 60 polypropylene suture around the major trunk of the left coronary artery or its prominent branches. The thread then was made into an overhand knot, an occluder, and two more threads were tied to the main knot (releasers) as described by Himori et al. [10]. Global ischemia was achieved by clamping the inflow tubing.
2.2. Assessment of cardiac function
A fluid-filled latex balloon connected to a transducer (Baxter, USA) with tubing was inserted into the left ventricle via the mitral valve. Balloon volume was adjusted to give a left ventricular end-diastolic pressure of 510 mmHg at the beginning of the experiment. Left ventricular developed pressure (LVDP) was calculated as the difference between left ventricular systolic and end-diastolic pressures. A stainless steel electrode was attached to the left auricle for unipolar electrogram recording relative to the metal aortic cannula. Total coronary flow (CF) was measured by timed collection of perfusate dripping from the right heart into a graduated cylinder. The intraventricular pressures, electrogram, heart temperature, and heart rate (HR) were displayed continuously using cardiomonitor (Hellige, Germany). The parallel registration of the intraventricular pressure and electrogram was done with chart recorder. Analyses of arrhythmia incidence were carried out in accordance with the Lambeth Conventions [11].
2.3. Experimental protocol and exclusion criteria
Forty-six hearts underwent the following protocol: after 20 min of stabilization, LCA was occluded for 30 min followed by 30 min of reperfusion. No heart had VF during ischemia. VF during reperfusion persisting until the 15th min of reperfusion was referred to as persistent VF. At this time point hearts that developed persistent VF were randomly assigned to one of the two groups: (1) controls (n=6), reperfusion was continued for 15 min without any intervention; (2) postconditioning (n=5), global ischemia was induced for 2 min followed by 13 min of reperfusion. The measurements of LVDP, HR and CF were made at baseline (i.e. at the end of stabilization), after 15 min of regional ischemia, and after 15 and 30 min of reperfusion.
Any heart with an HR less than 250 beats/min, or a CF more than 18 ml/min or less than 8 ml/min at the end of stabilization was excluded from the study. Hearts failing to develop left ventricular systolic pressure of more than 85 mmHg when the end-diastolic pressure was kept less than 10 mmHg were also excluded.
2.4. Statistical analysis
Differences in functional data at each time point were evaluated using one-way analysis of variance (ANOVA), followed by a Scheffe's posthoc test. Categorical data, i.e. VF incidence and appearance of regular rhythm, were compared with Fisher's test. All functional data are presented as mean±SD, and P-values less than 0.05 were considered significant.
| 3. Results |
|---|
|
|
|---|
|
|
| 4. Discussion |
|---|
|
|
|---|
Rhythm disturbances are one of the most important manifestations of myocardial reperfusion-induced injury. Reperfusion tachyarrhythmias may be a cause of sudden death in acute myocardial infarction [12] and may interfere with the recovery of heart function after cardioplegic arrest [13]. The mechanisms of reperfusion arrhythmias are complex and incompletely understood [14]. Among others, free radical formation and accentuation of preexisting heterogeneity of refractoriness occurring during reperfusion may be of primary importance [15,16]. One can assume that reintroduction of ischemia attenuates the formation of reactive oxygen species in the reperfused myocardium and thus interrupts one of the mechanisms of arrhythmia perpetuation. The study performed by Zhao et al. [8] demonstrated that postconditioning was associated with lower plasma levels of malondialdehyde, a product of lipid peroxidation. Furthermore, it has been shown in this study that tissue content of superoxide as revealed by dihidroethidium staining was significantly less in the area at risk myocardium of postconditioned dogs. Taken together, these results suggest reduced production of reactive oxygen species and attenuation of lipid peroxidation as possible mechanisms of the postconditioning phenomenon. On the other hand, global ischemia may make myocardium more electrically homogenous and, therefore, affect such a mechanism of arrhythmia as re-entrant circuits. However, exact mechanisms underlying the described effect remain to be investigated.
For this first study on postconditioning we performed global ischemia to avoid any mechanical interference with the delicate rat heart in the very sensitive and vulnerable period of reperfusion, as such maneuvers might in itself be arrhythmogenic. On the other hand, we have previously shown that reperfusion arrythmias can be mechanically converted in the isolated perfused rat heart [17]. One limitation of this study is the small number of hearts with persistent fibrillation. However, this is compensated by the clear picture of the effect: with postconditioning all five hearts with persistent fibrillation were converted compared to none among the six control hearts. Furthermore, the present study does not provide any information about protection of cardiac function evaluated by systolic or diastolic function, but it demonstrates protection against arrhythmias, which is one aspect of reperfusion injury. Another limitation is the lack of examination on possible molecular and electrophysiologic mechanisms. Finally, global ischemia in the isolated rat heart studying general principles may be far from the cardiac surgery scenario. Further studies should include more clinically relevant models.
In 1994 Grech and Ramsdale [18] reported that reinflation of the balloon during percutaneous transluminal coronary angioplasty terminated idioventricular rhythm caused by myocardial reperfusion and restored sinus rhythm. The authors suggested that this effect might be secondary to reinterruption of supply of oxygenated blood. This observation may be a clinical parallel to our experimental data, and also suggest that regional ischemia may be as effective as global ischemia. This is also the case in the pioneering study by Zhao and co-authors [8].
Postconditioning may become an alternative, or perhaps even an adjunct to preconditioning strategy to improve myocardial protection. However, it should be noted that the effect of postconditioning is directed specifically against reperfusion damage to the myocardium while preconditioning is known as a means of both ischemic and reperfusion injury prevention. Preconditioning is traditionally believed to be the most effective weapon against ischemic cell death, i.e. necrosis. How the relation of preconditioning to postconditioning will be, and if they act differently on the various aspects of reperfusion injury remains to be investigated.
Preconditioning is a powerful cardioprotective tool. However, it is only applicable in situations where we know that the ischemic insult is going to happen, such as cardioplegic arrest. However, there are still major limitations in the use of ischemic preconditioning in cardiac surgery [19], because there are serious contraindications to repeatedly clamp and declamp the ascending aorta at a time when one rather prefers surgical techniques with no-touch of the aorta. So far pharmacological preconditioning is not a part of clinical practice. Postconditioning has the advantage of being a way to influence and modify ischemia-reperfusion injury after it has occurred. This may open up a therapeutic alternative in situations of unexpected and uncontrolled ischemic injury, for instance in the situation where complications occur during surgery, making a simple procedure into a complicated one, and making aortic cross-clamping longer than anticipated. Furthermore, by studying the molecular mechanisms of postconditioning novel pharmacological strategies of myocardial protection may emerge.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. Luo, B. Li, R. Chen, R. Huang, and G. Lin Effect of ischemic postconditioning in adult valve replacement Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 203 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gomez, H. Thibault, A. Gharib, J.-M. Dumont, G. Vuagniaux, P. Scalfaro, G. Derumeaux, and M. Ovize Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1654 - H1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, B. Li, G. Lin, and R. Huang Postconditioning in cardiac surgery for tetralogy of Fallot J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1373 - 1374. [Full Text] [PDF] |
||||
![]() |
O. C. Manintveld, M. te Lintel Hekkert, E. J. van den Bos, G. M. Suurenbroek, D. H. Dekkers, P. D. Verdouw, J. M. Lamers, and D. J. Duncker Cardiac effects of postconditioning depend critically on the duration of index ischemia Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1551 - H1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Couvreur, L. Lucats, R. Tissier, A. Bize, A. Berdeaux, and B. Ghaleh Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1345 - H1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Zhao and J. Vinten-Johansen Postconditioning: Reduction of reperfusion-induced injury Cardiovasc Res, May 1, 2006; 70(2): 200 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gateau-Roesch, L. Argaud, and M. Ovize Mitochondrial permeability transition pore and postconditioning Cardiovasc Res, May 1, 2006; 70(2): 264 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Staat, G. Rioufol, C. Piot, Y. Cottin, T. T. Cung, I. L'Huillier, J.-F. Aupetit, E. Bonnefoy, G. Finet, X. Andre-Fouet, et al. Postconditioning the Human Heart Circulation, October 4, 2005; 112(14): 2143 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lucchinetti, R. da Silva, T. Pasch, M. C. Schaub, and M. Zaugg Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: evidence of opposing genomic responses in cardioprotection by pre- and postconditioning Br. J. Anaesth., August 1, 2005; 95(2): 140 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsang, D. J. Hausenloy, and D. M. Yellon Myocardial postconditioning: reperfusion injury revisited Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H2 - H7. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |